Patent · US Active

Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation

US12421506B2 · kind B2 · utility

0Cited by
38References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 16, 2020
Grant dateSep 23, 2025
Priority date
Expiry dateDec 26, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3519
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides for systems, methods, and compositions for altering expression of target gene sequences and related gene products. Provided are structural information on the Cas protein of the CRISPR-Cas system, use of this information in generating modified components of the CRISPR complex, vectors and vector systems which encode one or more components or modified components of a CRISPR complex, as well as methods for the design and use of such vectors and components. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system. In particular the present invention comprehends optimized functional CRISPR-Cas enzyme systems. In particular the present invention comprehends engineered new guide architectures to be used in optimized CRISPR-Cas enzyme systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.